Artificial intelligence (AI) is becoming important in many fields, including healthcare. In the United States, generative AI and AI agents are tools that can change how healthcare groups work. For medical practice leaders and IT managers, knowing the possible return on investment (ROI) and business growth from these tools is important. This article reviews recent studies and reports to show how generative AI and AI agents affect healthcare businesses, point out where they help most, and discuss challenges in healthcare settings.
Healthcare and life sciences groups in the US are slower to use “agentic AI” than other industries. According to a 2025 Google Cloud study, 52% of executives in different fields say they use AI agents now, and 39% say they have over ten AI agents working inside their companies. These AI agents are advanced computer models that can plan, think, and do tasks by themselves. They often make work easier and improve how companies interact with customers. But healthcare is behind fields like finance and retail in using these AI tools in daily work.
Medical leaders should know this delay comes partly because of strict data privacy laws, healthcare rules, and complex clinical settings that need special AI models. Still, the same study shows that groups who start using agentic AI early put at least half of their AI money into these agents and see an 88% rate of ROI. That is higher than the 74% ROI rate of all groups studied.
Generative AI and AI agents can boost productivity, improve patient and customer service, and lead to business growth in healthcare. The Google Cloud study says 74% of executives see good ROI within one year of starting generative AI projects. More than half (56%) link their AI work to business growth. Of these, 71% say their revenue went up by 6% to 10%.
This growth mostly comes from cutting waste, automating boring routine jobs, and making processes run better. This lets healthcare workers spend more time on good patient care. Also, better patient experience comes from faster replies, personal help, and steady communication. AI in customer service is one of the most common ways AI agents are used across industries.
In US healthcare, business growth from AI depends on smart investment in tools that improve work and clinical processes. Just using new technology for small gains is not enough. Making AI agents a key part of admin, clinical help, and patient contact can cause real change.
PwC’s research shows that groups that do well with AI focus leaders’ attention and funds on important workflows instead of many projects at once. For healthcare providers, this means picking certain tasks like patient scheduling, billing, front office, or clinical notes to improve with AI agents.
Automation is a big help in getting ROI and growth from AI agents. AI-driven workflow automation helps healthcare places make admin and clinical processes faster and use less staff time and money.
These automations help beyond office tasks by supporting medical staff and easing repeated jobs that don’t need expert judgment.
Even with clear benefits, adding AI agents in healthcare needs careful focus on data safety, privacy rules, and fitting systems together.
Success with AI in healthcare depends on clear, measurable goals. Metrics like shorter patient wait times, better appointment attendance, faster billing, and patient satisfaction scores show progress. Constant checks and controls help AI agents work right, follow rules, and adjust to new needs.
Oliver Parker from Google Cloud says early users change core business processes by using AI agents fully. They add AI into everyday work instead of treating it as extra. This change not only helps ROI but also keeps patient and operational work consistent.
In the US, AI use in healthcare is affected by local rules and market forces. Europe focuses more on AI tech support, and Asia-Pacific on customer service. US healthcare must handle complex rules and competition for new ideas.
Financial companies use AI agents for fraud detection (43%), and telecom firms for network automation (39%). Healthcare can learn from these to use AI for compliance checks, patient data quality, and automated reports, which now need lots of manual work.
Besides admin and operations, AI and machine learning (ML) affect clinical decisions and research, especially in pathology. The US & Canadian Academy of Pathology shows AI-ML tools help with image analysis, finding biomarkers, drug development, and speeding clinical trials.
Healthcare groups using AI should think about systems that combine many clinical and operation data sources. This can lead to personal patient care, better diagnosis, and well-planned treatments, improving patient health and practice reputation.
For healthcare leaders and IT managers in the US, investing in generative AI and AI agents needs a clear plan that focuses on measurable results, good management, and readiness to integrate. Starting with AI agents for front-office tasks like phone automation and patient communication can give quick ROI and better patient satisfaction.
Using AI agents in redesigned workflows helps practices work better, cut mistakes, and lets staff focus on complex care and new ideas. Privacy, system fitting, and costs are challenges that need strong leadership, central AI teams, and staff training.
More than half of executives worldwide already use AI agents and see ROI within a year. Healthcare providers that match AI investments to key operations and clinical needs can expect steady growth, better service, and a stronger position in a changing healthcare market.
52% of executives report their organizations are actively using AI agents, with 39% having launched more than ten AI agents within their companies.
Agentic AI early adopters represent 13% of executives whose organizations dedicate at least 50% of their future AI budget to AI agents and have deeply embedded agents across operations, achieving higher ROI with 88% seeing returns versus a 74% average.
Top areas include customer service and experience (43% early adopters vs. 36% average), marketing effectiveness (41% vs. 33%), security operations (40% vs. 30%), and software development improvements (37% vs. 27%).
AI agents enable standardized processes and automate complex tasks independently across locations, ensuring consistent execution, decision-making, and service delivery, reducing variability caused by human factors or regional differences.
Data privacy and security rank as the top concern (37%), followed by integration with existing systems and cost considerations, emphasizing the need for strong governance and modern data strategies.
Most industries show consistent adoption, with Healthcare & Life Sciences slightly lagging. Financial services focus on fraud detection (43%), retail on quality control (39%), and telecommunications on network automation (39%).
Europe prioritizes AI-enhanced tech support, JAPAC emphasizes customer service, and Latin America focuses on marketing, reflecting varied regional operational needs and market dynamics.
74% of executives report achieving ROI within the first year from generative AI initiatives, with over half (56%) linking these efforts to actual business growth and revenue increases.
Increased investment in AI, including reallocating budgets to generative AI (48%), correlates with reported business growth (56%) and revenue gains (53% of growth-driven organizations citing 6-10% growth).
Oliver Parker advises treating AI agents as core engines for competitive growth by securing dedicated budgets, redesigning business processes, and adopting modern data strategies with strong governance to overcome integration and security challenges.